Jeffrey M. Jonas, Director at Karuna Therapeutics, Inc. (KRTX), sold 26,620 shares at $198.41 ($5.2M) on 2023-08-01, disclosed to the SEC on 2023-08-02.
Scheduled sale ($5.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $194.78 | 3,399 | $662K | 12.7% |
| 2 | $194.78 | 3,399 | $662K | 12.7% |
| 3 | $195.61 | 6,301 | $1.2M | 23.7% |
| 4 | $195.61 | 6,301 | $1.2M | 23.7% |
| 5 | $196.59 | 3,110 | $611K | 11.7% |
| 6 | $196.59 | 3,110 |
| $611K |
| 11.7% |
| 7 | $197.66 | 400 | $79K | 1.5% |
| 8 | $198.41 | 600 | $119K | 2.3% |
| Total | $195.72 avg | 26,620 | $5.2M | 100% |
| Filing → |
| SAGE | SELL | 2023-02-10 | $1.0M | — | Filing → |
| SAGE | BUY | 2019-12-10 | $482K | — | Filing → |
| SAGE | SELL | 2019-05-29 | $29.9M | — | Filing → |